Oxycodone & oxymorphone DRI OXY

Ended Awarded Last action

Contract number
W91YTZ23F0024
Awardee
Awarding agency
Obligated
$28,200

Award facts

Contract value 100% obligated
$28,199.60 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Defense Health Agency Department of Defense
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Fort Meade, MD 20755, USA

Award details come from SAM.gov/FPDS.

Quick answers

Who was awarded contract W91YTZ23F0024?

W91YTZ23F0024 was awarded to Microgenics Corporation by Medical Command (Department of the Army) on November 17, 2022.

How much is contract W91YTZ23F0024 worth?

The government has obligated $28,200 on W91YTZ23F0024.

Which agency awarded contract W91YTZ23F0024?

Medical Command (Department of the Army) awarded W91YTZ23F0024, with funding from Defense Health Agency (Department of Defense).

Is contract W91YTZ23F0024 an order under another contract?

Yes. W91YTZ23F0024 is a delivery order under N6264518D5033, an indefinite delivery contract.

Was contract W91YTZ23F0024 competed?

The extent of competition for W91YTZ23F0024 was competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award